IHCM Appoints Dr Quazi Haque as Chief Executive Officer
Dr Haque brings extensive experience in leading and scaling mental health businesses. A co-founder of Elysium Healthcare, he was instrumental in building the business into one of the UK’s leading independent providers. Most recently as Chief Medical Officer at Elysium, part of Ramsay Health Care UK, he drove operational excellence and strategic portfolio development across a national network.
Throughout his career, Dr Haque has been a prominent voice influencing healthcare policy and practice. He combines two decades of clinical expertise as a Fellow of the Royal College of Psychiatrists and Institute of Directors, with proven business leadership advising specialist healthcare companies, health-tech boards and investor groups.
The mental health sector is evolving rapidly, creating exciting opportunities for providers who can deliver quality outcomes while adapting to new commissioning models. IHCM has tremendous potential—dedicated teams, strong clinical capabilities, and a real commitment to the people we support. I’m particularly energised by the positive culture I’ve seen and the opportunities to grow in emerging markets where demand for specialist services continues to increase. My focus will be on unlocking that potential through portfolio optimisation, strengthening our commercial position, and ensuring we’re the partner of choice for commissioners and families. Having built and scaled businesses in this sector, I know what’s possible when you combine great people with clear strategy.
– Dr Quazi Haque
Graham Sims, Chair, IHCM said “Dr Quazi brings exactly the combination of capabilities IHCM needs at this stage of our transformation, with a proven track record in managing strong teams, building successful mental health businesses, deep operational expertise, and has a strategic vision aligned to ours. His experience gives him unique insights into what drives sustainable performance in this sector and will help us navigate the current challenging market environment; I anticipate an exciting future for IHCM with Quazi joining us”.
Dr Haque, CEO will lead IHCM through its next phase of development, focusing on portfolio optimisation, consolidation execution, and strategic positioning for growth in both traditional NHS commissioning and emerging market segments.